Photronics Reports Fourth Quarter and Fiscal 2013 Results
-
Quarterly sales of
$106 million ; within revised guidance of$105 -$106 million -
Quarterly Non-GAAP diluted EPS of
$0.09 ; exceeds revised guidance of$0.06 -$0.07 -
Quarterly Non-GAAP EBITDA of
$27 million -
Quarterly high-end FPD sales increase 11% sequentially to
$18 million -
Working capital increases
$22 million sequentially to$214 million -
Net cash of
$22 million up$18 million sequentially
Constantine ("Deno") Macricostas, Photronics' chairman and chief
executive officer, commented: "Photronics' fourth-quarter revenues
reflect reduced high-end IC photomask sales, which were affected by
decreased demand in memory photomasks due to customer delays in
transitioning to new nodes and a delay in fully completing the
qualification process with a key Asian foundry customer. Even with
softer revenues, we delivered on the bottom line and achieved non-GAAP
net income of
"Following the fourth quarter we entered into an agreement with Dai
Nippon Printing Co. Ltd. (DNP) to form a joint venture in
Sales for the fourth quarter of fiscal 2013 were
Sales for the 2013 fiscal year were
The section below entitled "Non-GAAP Financial Measures" provides a
definition and information about the use of non-GAAP financial measures
in this press release, and the attached financial supplement reconciles
non-GAAP financial information with
Non-GAAP Financial Measures
Non-GAAP net income attributable to
- Transaction expenses related to the joint venture in the fourth quarter of fiscal 2013 are excluded because they are not a part of ongoing operations.
- Consolidation and restructuring charges in fiscal 2012 are excluded because they are not a part of ongoing operations.
- Impact related to warrants in fiscal 2012 is excluded because it does not affect cash earnings.
The presentation of this financial information should not be considered
in isolation or as a substitute for the financial information prepared
and presented in accordance with accounting principles generally
accepted in
A conference call with investors and the media to discuss these results
is scheduled for
The Private Securities Litigation Reform Act of 1995 provides a "safe
harbor" for forward-looking statements made by or on behalf of
18-2013
PLAB — E
|
|||||||||||||||||||||
Condensed Consolidated Statements of Income |
|||||||||||||||||||||
(in thousands, except per share amounts) | |||||||||||||||||||||
Three Months Ended | Year Ended | ||||||||||||||||||||
|
|
|
|
||||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||||||
Net sales | $ | 106,009 | $ | 104,219 | $ | 422,180 | $ | 450,439 | |||||||||||||
Costs and expenses: | |||||||||||||||||||||
Cost of sales | (79,334 | ) | (79,922 | ) | (322,540 | ) | (338,519 | ) | |||||||||||||
Selling, general and administrative | (12,928 | ) | (11,396 | ) | (48,213 | ) | (46,706 | ) | |||||||||||||
Research and development | (6,378 | ) | (5,264 | ) | (20,758 | ) | (19,371 | ) | |||||||||||||
Consolidation, restructuring and related charges | - | (246 | ) | - | (1,428 | ) | |||||||||||||||
Operating income | 7,369 | 7,391 | 30,669 | 44,415 | |||||||||||||||||
Other expense, net | (1,384 | ) | (1,623 | ) | (3,864 | ) | (3,767 | ) | |||||||||||||
Income before income taxes | 5,985 | 5,768 | 26,805 | 40,648 | |||||||||||||||||
Income tax provision | (1,072 | ) | (1,551 | ) | (7,229 | ) | (10,793 | ) | |||||||||||||
Net income | 4,913 | 4,217 | 19,576 | 29,855 | |||||||||||||||||
Net income attributable to noncontrolling interests | (73 | ) | (384 | ) | (1,610 | ) | (1,987 | ) | |||||||||||||
Net income attributable to |
$ | 4,840 | $ | 3,833 | $ | 17,966 | $ | 27,868 | |||||||||||||
Earnings per share: | |||||||||||||||||||||
Basic | $ | 0.08 | $ | 0.06 | $ | 0.30 | $ | 0.46 | |||||||||||||
Diluted | $ | 0.08 | $ | 0.06 | $ | 0.29 | $ | 0.44 | |||||||||||||
Weighted-average number of common shares outstanding: | |||||||||||||||||||||
Basic | 61,058 | 60,196 | 60,644 | 60,055 | |||||||||||||||||
Diluted | 61,962 | 61,052 | 61,599 | 76,464 | |||||||||||||||||
|
|||||||||
Condensed Consolidated Balance Sheets |
|||||||||
(in thousands) | |||||||||
|
|
||||||||
2013 | 2012 | ||||||||
Assets |
|||||||||
Current assets: | |||||||||
Cash and cash equivalents | $ | 215,615 | $ | 218,043 | |||||
Accounts receivable | 73,357 | 75,685 | |||||||
Inventories | 18,849 | 17,702 | |||||||
Other current assets | 10,645 | 8,364 | |||||||
Total current assets | 318,466 | 319,794 | |||||||
Property, plant and equipment, net | 422,740 | 380,808 | |||||||
Investment in joint venture | 93,124 | 93,252 | |||||||
Intangible assets, net | 34,080 | 37,384 | |||||||
Other assets | 17,519 | 17,996 | |||||||
$ | 885,929 | $ | 849,234 | ||||||
Liabilities and Equity |
|||||||||
Current liabilities: | |||||||||
Current portion of long-term borrowings | $ | 11,818 | $ | 7,781 | |||||
Accounts payable and accrued liabilities | 92,769 | 77,732 | |||||||
Total current liabilities | 104,587 | 85,513 | |||||||
Long-term borrowings | 182,203 | 168,956 | |||||||
Other liabilities | 11,308 | 8,764 | |||||||
Equity | 587,831 | 586,001 | |||||||
$ | 885,929 | $ | 849,234 | ||||||
|
|||||||||||
Condensed Consolidated Statements of Cash Flows |
|||||||||||
(in thousands) | |||||||||||
Year Ended | |||||||||||
|
|
||||||||||
2013 | 2012 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net income | $ | 19,576 | $ | 29,855 | |||||||
Adjustments to reconcile net income to net cash | |||||||||||
provided by operating activities: | |||||||||||
Depreciation and amortization | 72,942 | 85,209 | |||||||||
Consolidation, restructuring and related charges | - | 262 | |||||||||
Changes in assets and liabilities and other | 6,883 | 17,223 | |||||||||
Net cash provided by operating activities | 99,401 | 132,549 | |||||||||
Cash flows from investing activities: | |||||||||||
Purchases of property, plant and equipment | (63,792 | ) | (96,978 | ) | |||||||
Investment in joint venture | - | (13,397 | ) | ||||||||
Other | (2,445 | ) | (1,568 | ) | |||||||
Net cash used in investing activities | (66,237 | ) | (111,943 | ) | |||||||
Cash flows from financing activities: | |||||||||||
Proceeds from long-term borrowings | - | 25,000 | |||||||||
Repayments of long-term borrowings | (8,314 | ) | (5,293 | ) | |||||||
Repurchase of common stock of subsidiary | (32,374 | ) | (15,598 | ) | |||||||
Payments of deferred financing fees | (40 | ) | (198 | ) | |||||||
Proceeds from exercise of share-based arrangements | 884 | 653 | |||||||||
Net cash (used in) provided by financing activities | (39,844 | ) | 4,564 | ||||||||
Effect of exchange rate changes on cash | 4,252 | 2,945 | |||||||||
Net increase (decrease) in cash and cash equivalents | (2,428 | ) | 28,115 | ||||||||
Cash and cash equivalents, beginning of year | 218,043 | 189,928 | |||||||||
Cash and cash equivalents, end of year | $ | 215,615 | $ | 218,043 | |||||||
|
|||||||||||||||||||
Reconciliation of GAAP to Non-GAAP Financial Information |
|||||||||||||||||||
(in thousands, except per share data) | |||||||||||||||||||
(Unaudited) | |||||||||||||||||||
Three Months Ended | Year Ended | ||||||||||||||||||
|
|
|
|
||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||||
Reconciliation of GAAP to Non-GAAP Net Income |
|||||||||||||||||||
Attributable to |
|||||||||||||||||||
GAAP net income attributable to |
$ | 4,840 | $ | 3,833 | $ | 17,966 | $ | 27,868 | |||||||||||
(a) Joint venture transaction expenses, net of tax | 773 | - | 773 | - | |||||||||||||||
(b) Consolidation and restructuring charges, net of tax | - | 246 | - | 1,428 | |||||||||||||||
(c) Impact of warrants, net of tax | - | - | - | (94 | ) | ||||||||||||||
Non-GAAP net income attributable to |
$ | 5,613 | $ | 4,079 | $ | 18,739 | $ | 29,202 | |||||||||||
Reconciliation of GAAP to Non-GAAP Net Income |
|||||||||||||||||||
Applicable to Common Shareholders |
|||||||||||||||||||
Weighted average number of diluted shares outstanding | |||||||||||||||||||
GAAP | 61,962 | 61,052 | 61,599 | 76,464 | |||||||||||||||
Non-GAAP | 61,962 | 61,052 | 61,599 | 76,445 | |||||||||||||||
Net income per diluted share | |||||||||||||||||||
GAAP | $ | 0.08 | $ | 0.06 | $ | 0.29 | $ | 0.44 | |||||||||||
Non-GAAP | $ | 0.09 | $ | 0.07 | $ | 0.30 | $ | 0.46 | |||||||||||
(a) Represents transaction expenses in connection with the
joint venture with |
(b) Represents consolidation and restructuring charges primarily related to restructuring in Singapore. |
(c) Represents impact related to warrants, which is recorded in other expense, net. |
Vice President,
Investor Relations & Marketing
pbroadbent@photronics.com
Source:
News Provided by Acquire Media